Universität Heidelberg, Medizinische Fakultät

Heidelberg 69120 Heidelberg

1 studies enrolling now · 1 studies all time

What they study most

Melanoma, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors — Recruiting now